ACCELERA, a fully GLP and AAALAC accredited preclinical Contract Research Organization collaborating with more than 350 Sponsors in 25 countries, offers IND-enabling packages.

Based on our extensive experience in having conducted more than 80 Small Molecules, Large Molecules and ATMP projects, ACCELERA is committed to providing exactly what clients need with flexible and tailored-made solutions for preclinical studies.

Furthermore, ACCELERA can assist you with its team of internationally recognized experts in reproduction and developmental toxicity to perform all stages of DART studies.

* * * * * * * *

Visit ACCELERA Team

at the 57th Congress of the European Societies of Toxicology (EUROTOX 2023). Ljubljana, Slovenia, from 10 to 13 September 2023

Booth #43
Visit our booth for an overview of our services

Room: Poster Exhibition, Session P21-07#433,
September 11, 9.30 AM: PRECLINICAL ASSESSMENT OF CNS TOXICITY IN NEWBORN SPRAGUE-DAWLEY RATS: HISTOLOGICAL, HISTOCHEMICAL AND IMMUNOHISTOCHEMICAL EVALUATIONS

* * * * * * * *

To get in touch or arrange a meeting, please send an email to: info@accelera.org.

from NMSGroup